ATProto Browser

ATProto Browser

Experimental browser for the Atmosphere

Post

An ex-FDA employee who has tested ChatGPT as a clinical tool says the propensity of AI models to fabricate convincing information raises questions about how reliable such a chatbot might be. “Who knows how robust the platform will be for these reviewers’ tasks,” the ex-staffer says.

May 7, 2025, 8:02 PM

Record data

{
  "uri": "at://did:plc:inz4fkbbp7ms3ixufw6xuvdi/app.bsky.feed.post/3lom6vzm6f227",
  "cid": "bafyreihnoevag4bctz4bmxh62kbpvc3zrmulhvomhcdi4pdfgpfnnubnm4",
  "value": {
    "text": "An ex-FDA employee who has tested ChatGPT as a clinical tool says the propensity of AI models to fabricate convincing information raises questions about how reliable such a chatbot might be. “Who knows how robust the platform will be for these reviewers’ tasks,” the ex-staffer says.",
    "$type": "app.bsky.feed.post",
    "embed": {
      "$type": "app.bsky.embed.external",
      "external": {
        "uri": "https://www.wired.com/story/openai-fda-doge-ai-drug-evaluation/",
        "thumb": {
          "$type": "blob",
          "ref": {
            "$link": "bafkreidculcut3vonlefd3yhedsigjr37onhcr6xrb5osc5zx3s44ovdti"
          },
          "mimeType": "image/jpeg",
          "size": 470199
        },
        "title": "OpenAI and the FDA Are Holding Talks About Using AI In Drug Evaluation",
        "description": "High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT."
      }
    },
    "langs": [
      "en"
    ],
    "reply": {
      "root": {
        "cid": "bafyreigyd7ea3hel3rzblt7xqdglcw5ppowyilhg74gccr435pxpc73lna",
        "uri": "at://did:plc:inz4fkbbp7ms3ixufw6xuvdi/app.bsky.feed.post/3lom6tbalxk27"
      },
      "parent": {
        "cid": "bafyreigyd7ea3hel3rzblt7xqdglcw5ppowyilhg74gccr435pxpc73lna",
        "uri": "at://did:plc:inz4fkbbp7ms3ixufw6xuvdi/app.bsky.feed.post/3lom6tbalxk27"
      }
    },
    "createdAt": "2025-05-07T20:02:54.236Z"
  }
}